Abstract:Classical swine fever virus (CSFV) is a major animal pathogen threatening the global pork industry. To date, numerous anti-CSFV monoclonal antibodies (mAbs) and their recognizing epitopes have been reported. However, few mAbs were systematically characterized for the capacity to differentiate field CSFV isolates from CSF vaccine strains, and the molecular basis associated with antigenic differences between vaccines and field isolates is still largely unknown. In the present study, recombinant CSFV structural glycoproteins E2 of both virulent and vaccine strains and E rns of vaccine strain were expressed using eukaryotic cells and murine mAbs generated against E2 and E rns . After serial screening and cloning of the hybridomas, the viral spectra of mAbs were respectively determined by indirect fluorescent antibody assay (IFA) using 108 CSFVs, followed by Western blot analysis using expressed glycoproteins of all CSFV sub-genotypes including vaccine strains. The antigenic structures recognized by these mAbs were characterized by epitope mapping using truncated, chimeric, and site-directed mutated E2 and E rns proteins. We have identified two vaccine-specific, one field isolate-specific, and two universal CSFV-specific mAbs and five novel conformational epitopes with critical amino acid (aa) motifs that are associated with these five mAbs: 213 EPD 215 , 271 RXGP 274 , and 37 LXLNDG 42 on E2 and 38 CKGVP 42 , W 81 , and D 100 /V 107 on E rns . Particularly, E 213 of E2 is field isolate-specific, while N 40 of E2 and D 100 /V 107 of E rns are vaccine strain-specific. Results from our study further indicate that N 40 D of E2 mutation in field strains was likely produced under positive selection associated with long-term mass vaccination, leading to CSFV evasion of host immune response. Taking together, this study provides new insights into the antigenic structure of CSFV E2 and E rns and the differentiating mAbs will contribute to the development of a diagnostic strategy to differentiate C-strain vaccination from natural infection (DIVA) of CSFV in terms of elimination of CSF in China.

Purification of Classical Swine Fever Virus E2 Subunit Vaccines Based on High Affinity Peptide Ligand.

Specific Ligands for Classical Swine Fever Virus Screened from Landscape Phage Display Library.

Research Article an Improved Bac-to-Bac/BmNPV Technology Expressing Envelope E2 Glycoprotein of Classical Swine Fever Virus (CSFV) in the Silkworm, Bombyx Mori

Expression and purification of classical swine fever virus E2 protein from Sf9 cells using a modified vector

Identification of E2 Strain with Improved Secretion and Immunogenicity Against CSFV in Piglets

Expression of Classical Swine Fever Virus E2 Protein in Escherichia coli and Analysis of Its Immunogenicity

Expression of E2 Protein of Classical Swine Fever Virus Shimen Strain Using Baculovrius Expression System

Efficient Purification of Cell Culture-Derived Classical Swine Fever Virus by Ultrafiltration and Size-Exclusion Chromatography

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

Construction of a Chimeric Classical Swine Fever Virus C-strain Containing E2 of Group Ⅱ Isolate Remains and Its Biological Characteristics

A novel linear epitope at the C-terminal region of the classical swine fever virus E2 protein elicits neutralizing activity

Hypervariable Antigenic Region 1 of Classical Swine Fever Virus E2 Protein Impacts Antibody Neutralization.

Rice‐produced classical swine fever virus glycoprotein E2 with herringbone‐dimer design to enhance immune responses

Integrated System for Purification and Assembly of PCV Cap Nano Vaccine Based on Targeting Peptide Ligand

Candidate Multi-Peptide-Vaccine Against Classical Swine Fever Virus Induces Strong Antibody Response with Predefined Specificity

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Characterization of monoclonal antibodies that specifically differentiate field isolates from vaccine strains of classical swine fever virus

The Epitope Recognized by Monoclonal Antibody 2B6 in the B/C Domains of Classical Swine Fever Virus Glycoprotein E2 Affects Viral Binding to Hyperimmune Sera and Replication.

Identification of host cell binding peptide from an overlapping peptide library for inhibition of classical swine fever virus infection

[Molecular Cloning and Expression of E2 Gene of the Chinese Classical Swine Fever Virus(shimen Strain) and Preliminary Studies of Its DNA Vaccine].

Identification of neutralizing epitopes on the D/A domain of the E2 glycoprotein of classical swine fever virus